Antiproliferative Activity Predictor: A New Reliable In Silico Tool for Drug Response Prediction against NCI60 Panel (original) (raw)

Prediction of anticancer molecules using hybrid model developed on molecules screened against NCI-60 cancer cell lines

harinder singh

BMC cancer, 2015

View PDFchevron_right

Editorial: Computational drug discovery of medicinal compounds for cancer management

Faez I Khan

Frontiers in Chemistry, 2023

View PDFchevron_right

A facile in silico drug design strategy based on reference listed drugs and computational modeling of novel anticancer therapeutics

Asha Thomas

Sanat Tasarim Dergisi

View PDFchevron_right

In silico modelling of quantitative structure–activity relationship of multi-target anticancer compounds on k-562 cell line

Stephen Abechi

Network Modeling Analysis in Health Informatics and Bioinformatics, 2018

View PDFchevron_right

Insilico modelling of quantitative structure–activity relationship of pGI50 anticancer compounds on K-562 cell line

Stephen Abechi

Cogent Chemistry

View PDFchevron_right

Implementation of the NCI-60 Human Tumor Cell Line Panel to Screen 2260 Cancer Drug Combinations to Generate >3 Million Data Points Used to Populate a Large Matrix of Anti-Neoplastic Agent Combinations (ALMANAC) Database

Paul Johnston

2019

View PDFchevron_right

Implementation of the NCI-60 Human Tumor Cell Line Panel to Screen 2260 Cancer Drug Combinations to Generate >3 Million Data Points Used to Populate a Large Matrix of Anti-Neoplastic Agent Combinations (ALMANAC) Database

Paul Johnston

SLAS DISCOVERY: Advancing the Science of Drug Discovery

View PDFchevron_right

Data Mining the NCI60 to Predict Generalized Cytotoxicity

Adam Lee

Journal of Chemical Information and Modeling - J CHEM INF MODEL, 2008

View PDFchevron_right

CLC-Pred 2.0: A Freely Available Web Application for In Silico Prediction of Human Cell Line Cytotoxicity and Molecular Mechanisms of Action for Druglike Compounds

Vladimir Poroikov

International Journal of Molecular Sciences

View PDFchevron_right

CLC-Pred: A freely available web-service for in silico prediction of human cell line cytotoxicity for drug-like compounds

Vladimir Poroikov

PloS one, 2018

View PDFchevron_right

Computational modeling tool for biological activity assessment of drug candidate

BRAMAH HAZELA

2018

View PDFchevron_right

Computer-aided drug design and the biological evaluation of anti-cancer drugs

Razia Moorad

2016

View PDFchevron_right

Integrated Computational Analysis of Physicochemical Features, Biological Properties, Kinase Target Prediction and Biotransformation Pathways in Drug Discovery

Dhiya Eddine Bensaad, Mohamed Sabri BENSAAD

International Journal of Pharmacology, 2024

View PDFchevron_right

Computational Drug Target Screening through Protein Interaction Profiles

Fernanda Borges

Scientific Reports, 2016

View PDFchevron_right

Activity and toxicity modelling of some NCI selected compounds against leukemia P388ADR cell line using genetic algorithm-multiple linear regressions

Stephen Abechi

Journal of King Saud University - Science, 2018

View PDFchevron_right

Computational Strategies in Cancer Drug Discovery

Gabriela Wilson

Advances in Cancer Management, 2012

View PDFchevron_right

Chemoinformatics in Multi-target Drug Discovery for Anti-cancer Therapy: In Silico Design of Potent and Versatile Anti-brain Tumor Agents

Alejandro Speck-Planche

Anti-Cancer Agents in Medicinal Chemistry, 2012

View PDFchevron_right

Designing Focused Chemical Libraries Enriched in Protein-Protein Interaction Inhibitors using Machine-Learning Methods

Anne-claude Camproux

PLoS Computational Biology, 2010

View PDFchevron_right

Discovery of novel anti-proliferative compounds against A549 cells by virtual screening

M. Narasu

Chem-Bio Informatics Journal, 2010

View PDFchevron_right

Computational Screening for Active Compounds Targeting Protein Sequences: Methodology and Experimental Validation

Mingyue Zheng

Journal of Chemical Information and Modeling, 2011

View PDFchevron_right

In silico pharmacology for drug discovery: applications to targets and beyond

Jordi Mestres

British Journal of Pharmacology, 2007

View PDFchevron_right

ANN-QSAR model for selection of anticancer leads from structurally heterogeneous series of compounds

Humberto Santana Santana

European Journal of Medicinal Chemistry, 2007

View PDFchevron_right

Selected approaches for rational drug design and high throughput screening to identify anti-cancer molecules

Paul Diaz

Anti-cancer agents in medicinal chemistry, 2012

View PDFchevron_right

Identification of Potential p38γ Inhibitors via In Silico Screening, In Vitro Bioassay and Molecular Dynamics Simulation Studies

Siaw Hwang

International Journal of Molecular Sciences

View PDFchevron_right

Integrated in Silico Methods for the Design and Optimization of Novel Drug Candidates

Marjana Novič

Quantitative Structure-Activity Relationships in Drug Design, Predictive Toxicology, and Risk Assessment

View PDFchevron_right

Target Inhibition Networks: Predicting Selective Combinations of Druggable Targets to Block Cancer Survival Pathways

Bhagwan Yadav

PLoS Computational Biology, 2013

View PDFchevron_right

A Community Challenge for Pancancer Drug Mechanism of Action Inference from Perturbational Profile Data

Shuyu Zheng

SSRN Electronic Journal

View PDFchevron_right

Trainable structure–activity relationship model for virtual screening of CYP3A4 inhibition

Remigijus Didziapetris

Journal of Computer-Aided Molecular Design, 2010

View PDFchevron_right

Structure Activity Relationship of Antiproliferative Agents using Multiple Linear Regression

Leyte Winfield

Chemical Biology & Drug Design, 2009

View PDFchevron_right

Rational drug design for anti-cancer chemotherapy: Multi-target QSAR models for the in silico discovery of anti-colorectal cancer agents

Alejandro Speck-Planche

Bioorganic & Medicinal Chemistry, 2012

View PDFchevron_right

Antitumor Agents 252. Application of validated QSAR models to database mining: discovery of novel tylophorine derivatives as potential anticancer agents

Alexander Tropsha

Journal of Computer-Aided Molecular Design, 2007

View PDFchevron_right

Multi-Assay-Based Structure−Activity Relationship Models: Improving Structure−Activity Relationship Models by Incorporating Activity Information from Related Targets

Huzefa Rangwala

Journal of Chemical Information and Modeling, 2009

View PDFchevron_right